| 2023-06-08 | Sale | AtriCure, Inc. ATRC | director | 713 0.0015% | $47.89 | $34,146 | -25.66% | |
| 2016-03-08 | Sale | Boston Scientific Corporation BSX | SVP&Pres, Uro & Pelvic Health | 14,747 0.0011% | $17.27 | $254,749 | +31.76% | |
| 2016-02-08 | Sale | Boston Scientific Corporation BSX | SVP&Pres, Uro & Pelvic Health | 6,216 0.0005% | $16.05 | $99,785 | +39.33% | |
| 2015-07-07 | Sale | Boston Scientific Corporation BSX | SVP&Pres, Uro & Pelvic Health | 17,456 0.0013% | $17.66 | $308,308 | +0.56% | |
| 2015-03-03 | Sale | Boston Scientific Corporation BSX | SVP&Pres, Uro & Pelvic Health | 2,492 0.0002% | $16.79 | $41,838 | +4.95% | |
| 2015-02-27 | Sale | Boston Scientific Corporation BSX | SVP&Pres, Uro & Pelvic Health | 1,307 <0.0001% | $16.80 | $21,963 | +4.14% | |
| 2014-12-10 | Sale | Boston Scientific Corporation BSX | SVP&Pres, Uro & Pelvic Health | 19,753 0.0015% | $12.64 | $249,607 | +37.58% |